U.S. Entertainment Stock News

If you are wondering whether Bitmine Immersion Technologies at US$23.10 is still offering value or if the best opportunity has already passed, this breakdown will help you frame the stock in valuation terms instead of just headlines. The stock has been volatile, with a 7.5% return over the last week, 18.8% over the last month, a 25.9% decline year to date, and a 175.1% return over the last year. Recent market interest in Bitmine Immersion Technologies has been shaped by ongoing attention to...

Dorman Products (DORM) opened 2026 earnings season with Q1 numbers set against a recent run of steady results, including Q4 2025 revenue of US$537.9 million and basic EPS of US$0.38 on net income of US$11.6 million. Over the last six reported quarters, revenue has ranged between US$503.8 million and US$543.7 million while quarterly basic EPS has moved from US$1.77 to US$2.50, framing a business that has been consistently profitable. With a trailing 12 month net profit margin of 9.6% and...

In April 2026, Cypress Grove, Make Time Wellness and Pure Genius Protein each announced new distribution deals with Target, bringing premium goat cheeses, women’s wellness supplements and functional protein beverages into hundreds of Target stores and onto Target.com across major U.S. markets. These partnerships deepen Target’s role as a one-stop destination for specialty food and wellness products, enriching its assortment in higher-margin, trend-focused categories that can support its...

This article examines whether Merck, at around US$113 per share, still offers value or if most of the upside is already reflected in the price, by breaking down what the current valuation signals may be indicating. The stock has returned 2.8% over the last 7 days, is down 6.4% over the past 30 days, is up 6.3% year to date, and has delivered 48.4% over the past year. These moves may have influenced how the market views its risk and reward profile. Recent coverage has focused on Merck as a...

If you are wondering whether DHT Holdings at around US$19.10 is still good value or already pricing in a lot of optimism, the starting point is to look closely at what the market is paying for its fundamentals. The stock has recently posted returns of 4.4% over 7 days, 2.4% over 30 days, 62.7% year to date and 83.0% over the last year. This naturally raises questions about how much of the story is already reflected in the price. Recent news coverage has focused on DHT Holdings in the context...

Event context and recent stock performance Amalgamated Financial (AMAL) has drawn fresh attention after recent trading, with the stock closing at $41.35 and showing gains over the past month and past 3 months, as well as a 1 year total return above 40%. See our latest analysis for Amalgamated Financial. The recent 1 day share price return of 1.9% builds on a stronger year, with year to date share price gains alongside a 1 year total shareholder return of 43.0% and a 3 year total shareholder...

Oil States International (OIS) has just posted another quarter of figures that keep the focus squarely on profitability, with Q4 2025 revenue at US$178.5 million and a basic EPS loss of US$2.03 alongside a net income loss of US$117.0 million. Over the past year, the company has seen quarterly revenue range between US$159.9 million and US$178.5 million, while EPS has moved from a profit of US$0.05 in Q1 2025 to the Q4 loss of US$2.03, with trailing 12 month EPS at a loss of US$1.86 on revenue...

On April 28, 2026, Palantir announced a three-year partnership with Cleveland-Cliffs to embed artificial intelligence into production planning, order entry, and operational workflows across the steelmaker’s operations. This move highlights Cleveland-Cliffs’ push to digitalize a traditionally asset-heavy business, potentially affecting costs, service levels, and how it competes within the integrated steel industry. Now we’ll examine how Cleveland-Cliffs’ new AI partnership with Palantir could...

In recent weeks, TeraWulf Inc. completed a public offering of 54,510,000 common shares at US$19.00 each to help fund its planned Hawesville, Kentucky data center campus, repay a bridge credit facility, pursue future site acquisitions, and support general corporate needs. This funding, paired with the company’s shift from pure bitcoin mining toward AI and high-performance computing colocation services, underscores a broader repositioning as a diversified digital infrastructure provider. We’ll...

If you are wondering whether Estée Lauder Companies at around US$82.85 is giving you fair value, a discount, or an expensive ticket to future expectations, this breakdown is for you. The stock has returned 7.5% over the last week and 19.9% over the last month, while the 1 year return is 43.8%. However, the 3 year and 5 year returns are 56.5% and 69.8% declines, which raises real questions about how to read the current price. Recent coverage has focused on how the share price has moved...

Apple Hospitality REIT’s Q1 2026 Earnings Snapshot Apple Hospitality REIT (APLE) opened 2026 with Q1 Funds From Operations of US$76.5 million and trailing 12 month net profit margins of 12.4%, while the stock trades around US$13.61. Over the past reported quarters, revenue has moved from US$333.0 million in Q4 2024 to US$327.7 million in Q1 2025 and US$326.4 million in Q4 2025, alongside basic EPS readings between US$0.12 and US$0.27 and trailing 12 month FFO in the US$359.2 million range...

Ligand Pharmaceuticals recently raised its 2026 revenue guidance to a range of US$270 million to US$310 million and discussed its planned acquisition of XOMA Royalty, while also participating in several investor conferences, including the H.C. Wainwright Royalty Company Virtual Conference on May 6, 2026. This combination of higher guidance, an expanded royalty portfolio through the proposed XOMA Royalty acquisition, and active investor outreach could reshape how investors view Ligand’s...

Why Protagonist Therapeutics Stock Is Back in Focus Protagonist Therapeutics (PTGX) is in the spotlight after FDA approval of ICOTYDE for moderate to severe plaque psoriasis, a Priority Review for rusfertide, and a Takeda opt out that triggers substantial payments. See our latest analysis for Protagonist Therapeutics. Despite the recent pullback, with a 1-month share price return of 4.4% and a 7-day share price return of 2%, Protagonist Therapeutics still has a 90-day share price return of...

Progressive (NYSE:PGR) is expanding its UpPayment program to offer larger down payment assistance for first-time homebuyers. The initiative aims to support hundreds of eligible applicants as part of a broader push to make homeownership more accessible. The program expansion is positioned within Progressive's wider homeownership and community engagement efforts. Progressive, trading at around $197.74, is drawing attention not for its share price moves but for this new push into direct...

Initial market context for Universal Insurance Holdings (UVE) Universal Insurance Holdings (UVE) has drawn investor attention after recent share price moves, with the stock last closing at $39.77 and showing mixed short term performance alongside stronger one month and past three month returns. See our latest analysis for Universal Insurance Holdings. At a share price of $39.77, UVE’s recent 1 day gain and 7 day pullback sit against a stronger 30 day share price return of 19.43% and a 1 year...

In the first quarter of 2026, Illinois Tool Works Inc. reported sales of US$4,016 million and net income of US$768 million, with diluted earnings per share from continuing operations rising to US$2.66 from US$2.38 a year earlier. Alongside these results, the company lifted its 2026 GAAP EPS guidance, targeted higher operating margins backed by enterprise initiatives, and completed a multi‑year US$3.38 billion share repurchase program that reduced its share count by 4.54%. We’ll now examine...

Satellogic (NasdaqCM:SATL) has expanded its global sales organization with three senior industry veterans focused on sovereign geospatial intelligence customers. The hires are aimed at deepening relationships with defense and intelligence agencies and supporting the company's wider commercial push. For investors tracking NasdaqCM:SATL, these leadership additions come after the previously announced $12 million satellite transfer agreement and at a time when the stock is trading around $7.0...

VICI Properties (NYSE:VICI) completed a $1.2b sale leaseback acquisition of seven casinos from Golden Entertainment. The deal adds multiple Las Vegas area properties to VICI’s portfolio, expanding its role as a landlord in gaming real estate. Golden used transaction proceeds to address existing debt, while VICI secured new long term rental income streams. Alongside this transaction, VICI has announced new investments and an expansion into alternative experiential assets. For investors...

Giftify’s (NASDAQ:GIFT) CardCash approved over 100,000 customer orders in Q1 2026 while maintaining approval rates above 96%.

Wondering whether Atlassian at around US$92.35 is priced attractively or still looks expensive? This article breaks down what that current market price might imply about the stock's value. The share price has moved sharply in the short term, with a 32.5% return over the last 7 days and 35.2% over the last 30 days, while longer term returns sit at a 40.3% decline year to date and a 55.6% decline over the last year. Recent coverage has focused on Atlassian as a key software platform provider,...

Wondering if Ferrari stock at around US$325 is a premium worth paying or a potential bargain hiding in plain sight? This article walks through the key numbers so you can judge the value for yourself. The stock is down about 5% over the last 7 days, 4.3% over the last month, 12.5% year to date and 30.6% over the past year. Over a longer horizon, the 3 year and 5 year returns sit at 13.5% and 71.1% respectively. Recent coverage has focused on Ferrari as a high end auto stock, with attention on...

Henry Schein (HSIC) sets the stage with steady top line and consistent earnings Henry Schein (HSIC) opened Q1 2026 earnings season on the back of Q4 2025 revenue of about $3.4 billion and basic EPS of $0.86, with trailing twelve month figures at $13.2 billion of revenue and EPS of $3.29 helping frame the latest print. Over the past year, revenue has moved from $12.7 billion to $13.2 billion while trailing EPS shifted from $3.08 to $3.29, giving you a clearer sense of how the top line and per...

York Water’s latest earnings snapshot York Water (YORW) has just posted another quarter of steady utility earnings, with Q4 2025 revenue at US$19.5 million and basic EPS of US$0.36, supported by trailing 12 month revenue of US$77.5 million and EPS of US$1.39. Over recent quarters the company has seen revenue range between US$18.5 million and US$20.4 million, with quarterly EPS between US$0.25 and US$0.43. The trailing net profit margin sits at 25.9% compared with 27.1% a year earlier, which...

Exxon Mobil (XOM) opened 2026 with first quarter revenue of US$83.2b, basic EPS of US$1.00, and net income of US$4.2b, setting the tone for how the market will judge its latest move in profitability. Over the past year, revenue on a trailing basis has held around US$326.0b while trailing EPS has been about US$5.94, giving investors a clearer sense of how the current quarter fits into the recent earnings run rate. With the stock trading at US$154.88 and trailing net margin at 7.8% versus 9.8%...